title: Straylight before and after phacoemulsification in eyes with preoperative corrected distance visual acuity better than 0.1 logMAR.
abstract: OBJECTIVE
  To report the outcomes of changes in straylight before and after phacoemulsification in eyes with preoperative corrected distance visual acuity (CDVA) better than 0.1 logMAR.
  
  
  METHODS
  Private refractive surgery clinic, Driebergen, the Netherlands.
  
  
  METHODS
  Cohort study.
  
  
  METHODS
  Standard phacoemulsification with implantation of a monofocal or multifocal intraocular lens (IOL) was performed. Preoperative and 3-month postoperative straylight values, CDVA, and refractive error were compared.
  
  
  RESULTS
  The study enrolled 160 eyes (89 patients). The mean CDVA was 0.02 ± 0.05 logMAR (range -0.1 to 0.1 logMAR) preoperatively and 0.00 ± 0.04 logMAR (range -0.1 to 0.2 logMAR) postoperatively. The mean preoperative straylight was 1.21 ± 0.20 log(s) (range 0.80 to 1.74 log[s]) and 1.11 ± 1.16 log(s) (range 0.76 to 1.63 log[s]), respectively; the improvement was statistically significant. There was a correlation between high preoperative straylight values and postoperative improvement in straylight values.
  
  
  CONCLUSIONS
  In eyes with relatively good CDVA of 0.1 logMAR or better (decimal 0.8 or better; Snellen 20/25 or better), straylight improved by 0.10 log(s) after cataract surgery. A subgroup of 44 eyes had an improvement of more than 0.20 log(s), which is comparable to a 2-line improvement on the vision chart.
authors.affiliation: From the Department of Ophthalmology (Lapid-Gortzak, van der Meulen, Mourits), Academic Medical Center, University of Amsterdam, and the Netherlands Institute for Neurosciences (van den Berg), Royal Dutch Academy of Arts and Sciences, Amsterdam, and Retina Total Eye Care (Lapid-Gortzak, van der Meulen, van der Linden), Driebergen, the Netherlands. Electronic address: r.lapid@amc.nl.
authors.forename: Ruth
authors.initials: R
authors.lastname: Lapid-Gortzak
authors.affiliation: From the Department of Ophthalmology (Lapid-Gortzak, van der Meulen, Mourits), Academic Medical Center, University of Amsterdam, and the Netherlands Institute for Neurosciences (van den Berg), Royal Dutch Academy of Arts and Sciences, Amsterdam, and Retina Total Eye Care (Lapid-Gortzak, van der Meulen, van der Linden), Driebergen, the Netherlands.
authors.forename: Ivanka J E
authors.initials: IJ
authors.lastname: van der Meulen
authors.affiliation: From the Department of Ophthalmology (Lapid-Gortzak, van der Meulen, Mourits), Academic Medical Center, University of Amsterdam, and the Netherlands Institute for Neurosciences (van den Berg), Royal Dutch Academy of Arts and Sciences, Amsterdam, and Retina Total Eye Care (Lapid-Gortzak, van der Meulen, van der Linden), Driebergen, the Netherlands.
authors.forename: Jan Willem
authors.initials: JW
authors.lastname: van der Linden
authors.affiliation: From the Department of Ophthalmology (Lapid-Gortzak, van der Meulen, Mourits), Academic Medical Center, University of Amsterdam, and the Netherlands Institute for Neurosciences (van den Berg), Royal Dutch Academy of Arts and Sciences, Amsterdam, and Retina Total Eye Care (Lapid-Gortzak, van der Meulen, van der Linden), Driebergen, the Netherlands.
authors.forename: Maarten P
authors.initials: MP
authors.lastname: Mourits
authors.affiliation: From the Department of Ophthalmology (Lapid-Gortzak, van der Meulen, Mourits), Academic Medical Center, University of Amsterdam, and the Netherlands Institute for Neurosciences (van den Berg), Royal Dutch Academy of Arts and Sciences, Amsterdam, and Retina Total Eye Care (Lapid-Gortzak, van der Meulen, van der Linden), Driebergen, the Netherlands.
authors.forename: Thomas J T P
authors.initials: TJ
authors.lastname: van den Berg
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002386:Cataract / Q000503:physiopathology*; D015331:Cohort Studies; D005260:Female; D019466:Glare; D006801:Humans; D019654:Lens Implantation, Intraocular; D008027:Light; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D016896:Treatment Outcome; D014786:Vision Disorders / Q000503:physiopathology*; D014792:Visual Acuity / Q000502:physiology*